During the 2023 American Physical Therapy Association’s (APTA) Combined Sections Meeting, to be held February 23-25 in San Diego, California, Roswell Park Comprehensive Cancer Center physical therapists Carolyn Miller, DPT, and Hillary Jacobson, DPT, will present on a case study that showed benefits in utilizing body-weight support training as part of a cancer patient’s rehabilitation program. Andrew Ray, PhD, PT, Rehabilitation Specialist and co-author of the study, is co-moderating the oncology platform session.

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center. The study, “Association of neighborhood-level household income with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer,” appears today in JAMA Network Open.

Two experts from Roswell Park Comprehensive Cancer Center are delivering presentations this week at an international conference highlighting research aimed at extending and improving the lives of patients with blood-related cancers. Nataliya Buxbaum, MD, from the Department of Pediatric Oncology and Marco Davila, MD, PhD, Vice Chair for Cellular Therapies and Senior Vice President and Associate Director for Translational Research, were invited to highlight their work in podium talks at the 2023 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) this week in Orlando, Florida.

Investigators from Roswell Park Comprehensive Cancer Center are among the experts whose work will be highlighted February 15-19 at the 2023 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Orlando, Florida. The combined annual meetings promote the exchange of information about the latest discoveries in hematopoietic cell transplantation and cellular therapy for blood-related cancers, with the aim of extending patient survival and improving quality of life.